These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 16447121)
1. Poor infection control, not fluoroquinolones, likely to be primary cause of Clostridium difficile-associated diarrhea outbreaks in Quebec. Weiss K Clin Infect Dis; 2006 Mar; 42(5):725-7; author reply 727-9. PubMed ID: 16447121 [No Abstract] [Full Text] [Related]
2. Clostridium difficile-associated diarrhea outbreaks: the name of the game is isolation and cleaning. Beaulieu M; Thirion DJ; Williamson D; Pichette G Clin Infect Dis; 2006 Mar; 42(5):725; author reply 727-9. PubMed ID: 16447122 [No Abstract] [Full Text] [Related]
3. Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004. Weiss K; Bergeron L; Bernatchez H; Goyette M; Savoie M; Thirion D Int J Antimicrob Agents; 2007 Oct; 30(4):309-14. PubMed ID: 17644347 [TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile and fluoroquinolones: is there a link? Weiss K Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S29-32. PubMed ID: 19303566 [TBL] [Abstract][Full Text] [Related]
5. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Pépin J; Saheb N; Coulombe MA; Alary ME; Corriveau MP; Authier S; Leblanc M; Rivard G; Bettez M; Primeau V; Nguyen M; Jacob CE; Lanthier L Clin Infect Dis; 2005 Nov; 41(9):1254-60. PubMed ID: 16206099 [TBL] [Abstract][Full Text] [Related]
7. Update on the changing epidemiology of Clostridium difficile-associated disease. McFarland LV Nat Clin Pract Gastroenterol Hepatol; 2008 Jan; 5(1):40-8. PubMed ID: 18174906 [TBL] [Abstract][Full Text] [Related]
8. What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea? Blondeau JM J Antimicrob Chemother; 2009 Feb; 63(2):238-42. PubMed ID: 19028718 [TBL] [Abstract][Full Text] [Related]
11. C. difficile strain 20 times more virulent. Eggertson L CMAJ; 2005 May; 172(10):1279. PubMed ID: 15883397 [No Abstract] [Full Text] [Related]
12. Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea. Stepan C; Surawicz CM Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):295-305. PubMed ID: 19072422 [TBL] [Abstract][Full Text] [Related]
13. Established and potential risk factors for Clostridum difficile infection. Vaishnavi C Indian J Med Microbiol; 2009; 27(4):289-300. PubMed ID: 19736396 [TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada. Bourgault AM; Lamothe F; Loo VG; Poirier L; Antimicrob Agents Chemother; 2006 Oct; 50(10):3473-5. PubMed ID: 17005836 [TBL] [Abstract][Full Text] [Related]
15. [Clostridium difficile-associated diarrhea--an increasing problem. Reduce the administration of antibiotics and improve hygiene!]. Svenungsson B Lakartidningen; 1996 Aug; 93(35):2931-4. PubMed ID: 8815352 [No Abstract] [Full Text] [Related]
16. Clostridium difficile: changing epidemiology and new treatment options. Kuijper EJ; van Dissel JT; Wilcox MH Curr Opin Infect Dis; 2007 Aug; 20(4):376-83. PubMed ID: 17609596 [TBL] [Abstract][Full Text] [Related]